Predictive value of immune genes related to RAS/KIT mutations in the response of TGCT to cisplatin-based chemotherapy and immunotherapy

被引：0
|
作者：
Song, N. [1 ]
Ji, C. [1 ]
机构：
[1] Nanjing Med Univ, Dept Urol, Affiliated Hosp 1, Nanjing, Peoples R China
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0043
引用
收藏
页码：S732 / S732
页数：1
相关论文
共 38 条
  • [1] Predictive value of phenotypic signatures of bladder cancer response to cisplatin-based neoadjuvant chemotherapy
    Hensley, Patrick J.
    Kyprianou, Natasha
    Purdom, Matthew S.
    He, Daheng
    DiCarlo, Vincent
    Wang, Chi
    James, Andrew C.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (09) : 572.e1 - 572.e11
  • [2] Calretinin as a predictive biomarker of response to cisplatin-based chemotherapy in malignant mesothelioma
    Zupanc, Cita
    Franko, Alenka
    Strbac, Danijela
    Kovac, Viljem
    Dolzan, Vita
    Goricar, Katja
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1188 - 1188
  • [3] Microsatellite instability is not related to response to cisplatin-based chemotherapy in cervical cancer
    Ercoli, A
    Ferrandina, G
    Genuardi, M
    Zannoni, GF
    Cicchillitti, L
    Raspaglio, G
    Carrara, S
    Mancuso, S
    Scambia, G
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 (02) : 308 - 311
  • [4] Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer
    Gil Jimenez, Albert
    van Dorp, Jeroen
    Contreras-Sanz, Alberto
    van der Vos, Kristan
    Vis, Daniel J.
    Braaf, Linde
    Broeks, Annegien
    Kerkhoven, Ron
    van Kessel, Kim E. M.
    Ribal, Maria Jose
    Alcaraz, Antonio
    Wessels, Lodewyk F. A.
    Seiler, Roland
    Wright, Jonathan L.
    Mengual, Lourdes
    Boormans, Joost
    van Rhijn, Bas W. G.
    Black, Peter C.
    van der Heijden, Michiel S.
    EUROPEAN UROLOGY, 2023, 83 (04) : 313 - 317
  • [5] Predictive factors of response to cisplatin-based chemotherapy and the relation of response to survival in patients with metastatic urothelial cancer
    Lisa Sengeløv
    Claus Kamby
    Poul Geertsen
    Lisbeth Juhler Andersen
    Hans von der Maase
    Cancer Chemotherapy and Pharmacology, 2000, 46 : 357 - 364
  • [6] Predictive factors of response to cisplatin-based chemotherapy and the relation of response to survival in patients with metastatic urothelial cancer
    Sengelov, L
    Kamby, C
    Geertsen, F
    Andersen, LJ
    von der Maase, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 46 (05) : 357 - 364
  • [7] Re: Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer
    Cheng, Chunliang
    Hu, Jiao
    Chen, Jinbo
    EUROPEAN UROLOGY, 2023, 83 (06) : E159 - E160
  • [8] Predictive value of dendritic cell-related genes for prognosis and immunotherapy response in lung adenocarcinoma
    Sun, Zihao
    Hu, Mengfei
    Huang, Xiaoning
    Song, Minghan
    Chen, Xiujing
    Bei, Jiaxin
    Lin, Yiguang
    Chen, Size
    CANCER CELL INTERNATIONAL, 2025, 25 (01)
  • [9] Sarcopenia as a Predictive Factor for Response to Upfront Cisplatin-Based Chemotherapy in Patients with Muscle-Invasive Urothelial Bladder Cancer
    Stangl-Kremser, Judith
    Mari, Andrea
    D'Andrea, David
    Kimura, Shoji
    Resch, Irene
    Shariat, Shahrokh F.
    Klatte, Tobias
    UROLOGIA INTERNATIONALIS, 2018, 101 (02) : 197 - 200
  • [10] Predictive Value of the ERCC1 Expression for Treatment Response and Survival in Advanced Gastric Cancer Patients Receiving Cisplatin-based First-line Chemotherapy
    Yun, Jina
    Kim, Kyoung-Mee
    Kim, Seung Tae
    Kim, Jung-Hoon
    Kim, Jung A.
    Kong, Jee Hyun
    Lee, Soo Hyeon
    Won, Young-Woong
    Sun, Jong-Mu
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    CANCER RESEARCH AND TREATMENT, 2010, 42 (02): : 101 - 106
1234